Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
3
×
pfizer
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
celgene
detroit blog main
detroit top stories
genentech
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
starboard value
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
acc
acne
acquisition
activist investor
aducanumab
What
approved
3
×
bio
3
×
companies
drug
merck
news
roundup
adu
beats
bids
biogen
cancer
combo
complicated
dating
depression
digital
dire
disease
epidemic
fatty
fda
frenzied
game
good
group
growing
happening
heart
help
immunotherapies
kgaa
known
led
liver
medical
medications
nash
need
oncolytics
Language
Current search:
bio
×
approved
×
" national blog main "
×
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More